Anti-Cancer Agents in Medicinal Chemistry
Title:Meet Our Editorial Board Member
Volume: 19 Issue: 4
Author(s): Ana Conejo-García
Affiliation:
Export Options
About this article
Cite this article as:
Conejo-García Ana , Meet Our Editorial Board Member , Anti-Cancer Agents in Medicinal Chemistry 2019; 19 (4) . https://dx.doi.org/10.2174/187152061904190521100727
DOI https://dx.doi.org/10.2174/187152061904190521100727 |
Print ISSN 1871-5206 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5992 |
15
2
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
DNA Repair and Resistance to Topoisomerase I Inhibitors: Mechanisms, Biomarkers and Therapeutic Targets
Current Medicinal Chemistry In Silico Machine Learning Methods in Drug Development
Current Topics in Medicinal Chemistry Non Alcoholic Fatty Liver: Epidemiology and Natural History
Reviews on Recent Clinical Trials Phytosterols: Perspectives in Human Nutrition and Clinical Therapy
Current Medicinal Chemistry The Dual Role of Tumor Necrosis Factor (TNF) in Cancer Biology
Current Medicinal Chemistry Inhibition of Migration and Invasion of Hepatocarcinoma HepG2 Cells by Dietary Saponins via Targeting HIF-1α
Anti-Cancer Agents in Medicinal Chemistry Recent Patents Concerning Modulators of Protein Kinase C
Recent Patents on DNA & Gene Sequences Low Testosterone Levels and Metabolic Syndrome in Aging Male
Current Pharmaceutical Design Breast Cancer: Biological Characteristics in Postmenopausal Type 2 Diabetic Women. Identification of Therapeutic Targets
Current Drug Targets - Immune, Endocrine & Metabolic Disorders The Role of Tumor Suppressor Dysregulation in Prostate Cancer Progression
Current Drug Targets Patent Selections
Recent Patents on CNS Drug Discovery (Discontinued) Radiative Transfer Models: Available Tools, Patents and Commercial Potential to Remote Sensing
Recent Patents on Space Technology Synthesis and Biological Properties of Dihydro-Oxadiazine-Based Heterocyclic Derivatives
Mini-Reviews in Medicinal Chemistry Role of mTOR Signaling in Tumor Cell Motility, Invasion and Metastasis
Current Protein & Peptide Science Knockdown of Insulin-Like Growth Factor I Receptor Inhibits the Growth and Enhances Chemo-Sensitivity of Liver Cancer Cells
Current Cancer Drug Targets RAGE and RAGE Ligands in Cancer
Current Molecular Medicine The Effect of PDE5 Inhibitors on the Male Reproductive Tract
Current Pharmaceutical Design Chalcones as Versatile Synthons for the Synthesis of 5- and 6-membered Nitrogen Heterocycles
Current Organic Chemistry New Preparative Approaches for Micro and Nano Drug Delivery Carriers
Current Drug Delivery Author index to volume 3
Current Cancer Drug Targets